AKT1

About

Location: 14q32.33

Mappings

HGNC: HGNC:391

Ensembl: NM_001382430.1

NCBI: ENSG00000142208

Refseq: 207

Biomarkers

AKT1 is involved in the following curated biomarkers.

Name Biomarker type Propositions Statements
AKT1 amplification Copy Number 3 4
AKT1 somatic variants Somatic Variant 3 4

Therapeutic response

Precision oncology relationships for therapeutic response involving this gene.

Type Biomarker(s) Cancer type Therapy(ies)
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative, PR positive Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 amplification, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant
Sensitivity (+) AKT1 somatic variants, ER positive, HER2-negative Invasive Breast Carcinoma Capivasertib, Fulvestrant